Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype

Wolfram syndrome (WS), also known as a DIDMOAD (diabetes insipidus, early-onset diabetes mellitus, optic nerve atrophy and deafness) is a rare autosomal disorder caused by mutations in the Wolframin1 (<i>WFS1</i>) gene. Previous studies have revealed that glucagon-like peptide-1 receptor...

詳細記述

書誌詳細

出版年:	Cells
主要な著者:	Toomas Jagomäe, Kadri Seppa, Riin Reimets, Marko Pastak, Mihkel Plaas, Miriam A. Hickey, Kaia Grete Kukker, Lieve Moons, Lies De Groef, Eero Vasar, Allen Kaasik, Anton Terasmaa, Mario Plaas
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2021-11-01
主題:	wolfram syndrome Wfs1 GLP1 receptor agonist liraglutide rat model neurodegeneration
オンライン･アクセス:	https://www.mdpi.com/2073-4409/10/11/3193